Cargando…
Recombinant human arginase induced caspase-dependent apoptosis and autophagy in non-Hodgkin's lymphoma cells
Arginase, an arginine-degrading enzyme, has gained increased attention recently as a new experimental therapeutics for a variety of malignant solid cancers. In this study, we found that recombinant human arginase (rhArg) could induce remarkable growth inhibition, cell cycle arrest, and caspase-depen...
Autores principales: | Zeng, X, Li, Y, Fan, J, Zhao, H, Xian, Z, Sun, Y, Wang, Z, Wang, S, Zhang, G, Ju, D |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3824669/ https://www.ncbi.nlm.nih.gov/pubmed/24113174 http://dx.doi.org/10.1038/cddis.2013.359 |
Ejemplares similares
-
Blocking autophagy enhanced cytotoxicity induced by recombinant human arginase in triple-negative breast cancer cells
por: Wang, Z, et al.
Publicado: (2014) -
Autophagy Plays a Critical Role in ChLym-1-Induced Cytotoxicity of Non-Hodgkin’s Lymphoma Cells
por: Fan, Jiajun, et al.
Publicado: (2013) -
The prognostic value of the myeloid-mediated immunosuppression marker Arginase-1 in classic Hodgkin lymphoma
por: Romano, Alessandra, et al.
Publicado: (2016) -
Dysregulated autophagy contributes to caspase-dependent neuronal apoptosis
por: Chung, Yuhyun, et al.
Publicado: (2018) -
A novel and promising therapeutic approach for NSCLC: recombinant human arginase alone or combined with autophagy inhibitor
por: Shen, Weitao, et al.
Publicado: (2017)